Lingotto Investment Management LLP Has $26.46 Million Stock Holdings in Tempus AI, Inc. (NASDAQ:TEM)

Lingotto Investment Management LLP decreased its holdings in shares of Tempus AI, Inc. (NASDAQ:TEM) by 16.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 783,859 shares of the company’s stock after selling 150,000 shares during the period. Tempus AI accounts for about 0.7% of Lingotto Investment Management LLP’s portfolio, making the stock its 19th biggest position. Lingotto Investment Management LLP owned 0.50% of Tempus AI worth $26,463,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Kovitz Investment Group Partners LLC bought a new stake in Tempus AI in the third quarter valued at $1,367,000. China Universal Asset Management Co. Ltd. acquired a new stake in shares of Tempus AI in the 4th quarter valued at about $1,091,000. Sumitomo Mitsui Trust Group Inc. increased its position in Tempus AI by 1,591.2% in the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,217,699 shares of the company’s stock valued at $68,922,000 after buying an additional 1,145,698 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new position in Tempus AI during the 4th quarter worth approximately $178,000. Finally, Captrust Financial Advisors bought a new position in Tempus AI in the third quarter worth approximately $2,726,000. Institutional investors and hedge funds own 24.22% of the company’s stock.

Analyst Ratings Changes

TEM has been the topic of a number of research reports. Bank of America upped their target price on Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a research report on Friday, December 13th. JPMorgan Chase & Co. downgraded shares of Tempus AI from an “overweight” rating to a “neutral” rating and upped their price objective for the stock from $50.00 to $55.00 in a report on Tuesday. Loop Capital reduced their price objective on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a report on Tuesday, January 14th. TD Cowen reissued a “buy” rating and set a $74.00 target price (up from $58.00) on shares of Tempus AI in a research report on Wednesday, February 5th. Finally, Piper Sandler reaffirmed a “neutral” rating and issued a $70.00 price target (up previously from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Five analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $60.55.

Tempus AI Stock Performance

Tempus AI stock opened at $59.10 on Wednesday. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The company’s 50 day moving average price is $51.28 and its two-hundred day moving average price is $52.17. Tempus AI, Inc. has a 52 week low of $22.89 and a 52 week high of $91.45.

Insider Buying and Selling

In other Tempus AI news, EVP Andrew Polovin sold 51,504 shares of Tempus AI stock in a transaction dated Wednesday, December 11th. The shares were sold at an average price of $42.39, for a total value of $2,183,254.56. Following the sale, the executive vice president now owns 246,085 shares of the company’s stock, valued at approximately $10,431,543.15. The trade was a 17.31 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Jennifer A. Doudna sold 1,320 shares of the stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $90.00, for a total transaction of $118,800.00. Following the transaction, the director now directly owns 36,011 shares of the company’s stock, valued at $3,240,990. This represents a 3.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 2,583,467 shares of company stock worth $130,542,311.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.